Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s share price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $10.55 and traded as low as $8.1650. Ampliphi Biosciences shares last traded at $8.82, with a volume of 59,763 shares changing hands.
Ampliphi Biosciences Stock Up 6.3%
The business’s 50 day moving average is $10.55 and its two-hundred day moving average is $8.04.
Ampliphi Biosciences Company Profile
Ampliphi Biosciences, Inc is a clinical‐stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the discovery and development of novel therapies to prevent and treat life‐threatening drug‐resistant infections. The company’s core mission is to address the growing global threat of antibiotic resistance by advancing first‐in‐class and best‐in‐class antibacterial agents through late‐stage clinical trials.
The company’s lead product candidate, exeporfinium chloride (XF-73), is a pioneering topical antibacterial designed for pre‐operative nasal decolonization of Staphylococcus aureus in patients undergoing high‐risk surgical procedures.
See Also
- Five stocks we like better than Ampliphi Biosciences
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
